20519 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
Glycan therapeutics and related methods thereof
#302Amylase inhibitor compounds, methods of their use and compositions thereof
#303PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#304Cholestosome vesicles for incorporation of molecules into chylomicrons
#305ANTIMICROBIAL ARTICLES PRODUCED BY ADDITIVE MANUFACTURING
#306PHARMACEUTICAL COMPOSITION FOR PROMOTING NEUROGENESIS AND METHOD OF UTILIZING GASTRODIA ELATA EXTRACT OR ADENOSINE ANALOG FOR PROMOTING NEUROGENESIS
#307CONSUMABLE WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY
#308CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USE
#309WEIGHT LOSS COMPOSITION INCLUDING CHLOROGENIC ACIDS AND PROBIOTICS
#310Immunodulating small molecules
#311PROPHYLACTIC AND THERAPEUTIC DRUG FOR NONALCOHOLIC FATTY LIVER DISEASE
#312Formulation and Process for Modulating Wound Healing
#313Compositions And Methods For Immunotherapy
#314Composition for cough
#315APPLICATION OF VERBASCOSIDE IN TREATMENT AND PREVENTION OF TYPE II DIABETIC KIDNEY DISEASE
#316Anti-5T4 antibody-drug conjugate and use thereof
#317Nanoparticle delivery system for targeted anti-obesity treatment
#318TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#319Pharmaceutical composition, methods for treating and uses thereof
#320METHOD OF REGULATING THE CIRCADIAN RHYTHM OF AN INDIVIDUAL COMPRISING ADMINISTERING AN EFFECTIVE AMOUNT OF A CIRCADIAN RHYTHM REGULATOR CONTAINING 1,2-DI-O-GALLOYL-4,6-O-(S)-HEXAHYDROXYDIPHENOYL-B-D-GLUCOSE
#321Ergostenol glycoside derivative
#322DIABETES POLYGENIC RISK SCORE
#323HIGH-PURITY STEVIOL GLYCOSIDES
#324Probiotic recolonisation therapy
#325HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN
#326N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM
#327PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE
#328Acylated compounds for the treatment of ocular pathologies
#329Composition comprising pollen and/or pistil extracts, preparation process and associated uses
#330COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#331Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
#332Preparation of a composition containing stilbene glycoside
#333Pharmaceutical composition for preventing or treating dementia and improving cognitive function, comprising glasswort extract
#334Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes
#335Pharmaceutical composition for preventing or treating liver diseases, containing licorice extract containing glycyrrhizin and liquiritin
#336Compositions and methods for protecting organs from ischemia/reperfusion injury associated with transplantation
#337PHARMACEUTICAL COMPOSITION OF DAPAGLIFLOZIN
#338Mannose derivatives for treating bacterial infections
#339Systems and methods for thrombosis prevention
#340Saffron extract and its use for the prevention of mood disorders related to depression
#3414-methylcatechol Derivatives and Uses Thereof
#342Treatments and formulations comprising Torsemide
#343Simmondsin formulation
#344Identification and characterization of UDP-glucose:phloretin 4′-O-glucosyl transferase from Borkh
#345Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
#346Glycomimetic inhibitors of PA-IL and PA-IIL lectins
#347COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS AND HEPATOSTEATOSIS AND OTHER DISEASES
#348Dicaffeoyl spermidine cyclized derivatives and use thereof
#349Formulation and process for modulating wound healing
#350Phenylpropanoid compound and preparation method and use thereof
#351Compounds for inhibiting cancer and virus
#352PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#353C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same
#354Anti-aging agent and anti-aging composition for skin
#355Probiotic recolonisation therapy
#356extract
#357Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm
#358ANTIBODIES FOR TARGETING CANCER STEM CELLS AND TREATING AGGRESSIVE CANCERS
#359COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#360Methods and compositions for treatment of COPD diseases
#361Compositions and methods for treatment of inflammatory disorders
#362Cannabinoid glycoside prodrugs and methods of synthesis
#363SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
#364Methods of use for oenothein A and B from species
#365BUCKWHEAT HONEY AND POVIDONE-IODINE WOUND HEALING DRESSING
#366METHODS FOR THE MOBILIZATION AND USE OF T-CELLS WITH ENHANCED RECONSTITUTION POTENTIAL AND LIFE-SPAN
#367Anticancer composition and use thereof
#368Tunicamycin related compounds with anti-bacterial activity
#369Pharmaceutical composition, methods for treating and uses thereof
#370COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#371Method for treating or preventing dry eyes
#372METHODS FOR DOWNREGULATING APOBEC3B
#373METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#374ANHYDROUS CRYSTALLINE FORM OF (1S)-1,5-ANHYDRO-1-[3-[[5-(4-FLUOROPHENYL)-2-THIENYL]METHYL]-4-METHYLPHENYL]-D-GLUCITOL
#375LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#376Antibacterial products
#377Methods of treating a treatment-resistant gastrointestinal spasm with an oxidized tannin
#378Anticancer adjuvant containing panaxadiol ginsenocide compound
#379Method of treating focal segmental glomerulosclerosis
#380Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
#381Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders
#382ENGINEERED SITE-SPECIFIC ANTIBODIES AND METHODS OF USE
#383Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain
#384Methods of preparing steviol glycosides and uses of the same
#385Composition containing stilbene glycoside and preparation and uses thereof for treating diabetes
#386E-selectin antagonist compounds, compositions, and methods of use
#387Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
#388Phillygenin glucuronic acid derivative as well as preparation method and application thereof
#389Compositions and Methods for Managing or Improving Bone Disorders, Cartilage Disorders, or Both
#390COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN
#391Fast acting joint relief formulations
#392Cholestosome vesicles for incorporation of molecules into chylomicrons
#393COMBINATION COMPRISING AN OMEGA-3 FATTY ACID COMPOSITION AND AN SGLT2 INHIBITOR
#394Methods of treating a treatment-resistant gastrointestinal spasm
#395Nanoparticle delivery system for targeted anti-obesity treatment
#396METHOD FOR MANUFACTURING SMILAX CHINA L. ROOT EXTRACT HAVING INCREASED ACTIVE INGREDIENTS AND BEVERAGE COMPOSITION CONTAINING THE EXTRACT FOR DETOXIFICATION
#397Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#398BILAYER TABLET FORMULATIONS
#399SKIN BARRIER FUNCTION-IMPROVING AGENT AND COMPOSITION FOR IMPROVING SKIN BARRIER FUNCTION
#400PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#401COMPOSITIONS USEFUL FOR THE PREVENTION AND/OR TREATMENT OF INFECTIONS AND INFLAMMATIONS
#402METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
#403GPR40 agonists in anti-diabetic drug combinations
#404COMPOSITIONS FOR THE TREATMENT OF AGE RELATED DISORDERS
#405Method of treating neuropathic pain with a synergistic pharmaceutical composition comprising palmitoylethanolamide and L-acetylcarnitine
#406Compounds and methods for treating bacterial infections
#407Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization
#408ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE
#409ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE
#410Adaptogenic compositions and applications thereof
#411Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
#412Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
#413Potentiated antimicrobial agents
#414Composition for external application
#415Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells
#416USE OF SUBSTITUTED CHROMAN COMPOUNDS
#417METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS
#418PHARMACEUTICAL COMPOSITION FOR TREATING CARDIO-CEREBROVASCULAR DISEASES AND METHOD FOR PREPARING THE SAME
#419Combination therapy for the treatment of diabetes
#420COMPOSITIONS AND METHODS OF IMPROVING PERFORMANCE AND INTESTINAL HEALTH OF POULTRY
#421Dressing for promotion of wound healing
#422Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
#423Process for the Extraction of Strawberry P-Coumaroyl Hexose and/or Polyphenols, Extract and Uses Thereof
#424TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#425Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#426Combination of biologically active substances for treatment of hyperglycaemic disorders
#427Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
#428Treatment of metabolic disorders in equine animals
#429Fast acting joint relief formulations
#430Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
#431Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
#432Drug delivery composition comprising a self-assembled gelator
#433Skin aging inhibitor and concentrate of resveratrol 3-O-α-glucoside
#434Compounds as positive allosteric modulators for erythropoietin and erythropoietin receptor to treat erythropoietin deficiency diseases
#435Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#436PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#437ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE
#438Methods of treating gastroesophageal reflux disease
#439COMPOSITION AND METHOD OF DELIVERY OF L-ARABINOSE AND SELECT COMPOUNDS
#440Probiotic recolonisation therapy
#441Probiotic recolonisation therapy
#442Probiotic recolonisation therapy
#443Treatment of metabolic disorders in canine animals
#444EDIBLE COMPOSITION INCLUDING SAFRANAL, CROCIN, PICROCROCIN AND A VITAMIN B COMPLEX FOR TREATING THE INITIAL PHASE OF DEPRESSION
#4454-methylcatechol Derivatives and Uses Thereof
#446Systems and methods for thrombosis prevention
#447E-SELECTIN INHIBITION WORKS IN COMBINATION WITH LOW-MOLECULAR WEIGHT HEPARIN TO DECREASE VENOUS THROMBOSIS AND BLEEDING RISK
#448Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#449Antibiotic formulations, unit doses, kits, and methods
#450Combination of bezafibrate and of resveratrol or resveratrol derivatives for the treatment and prevention of diseases involving a mitochondrial energy dysfunction
#451Castration-resistant prostate cancer
#452Methods of inhibiting a bacterial virulence in a subject
#453COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#454Formulation and process for modulating wound healing
#455Probiotic recolonisation therapy
#456Probiotic recolonisation therapy
#457Fibrosis Inhibiting Compounds and Methods of Use Thereof in the Prevention or Treatment of Fibrosing Diseases
#458Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
#459Antiangiogenic use of liquid phytocomplexes from olive
#460EXTRACTS FROM PLANTS OF THE MORINGACEAE FAMILY AND METHODS OF MAKING
#461METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
#462Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
#463Mannose derivatives for treating bacterial infections
#464Nanoparticle delivery system for targeted anti-obesity treatment
#465Targeting the EGFR-SGLT1 interaction for cancer therapy
#466Tablets containing a 1-(β-D-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound
#467CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USE
#468Cocoa polyphenols and their use in the treatment or prevention of eosinophilic esophagitis
#469Glycan therapeutics and related methods thereof
#470Compositions Associated with and Methods of Managing Neutrophil Movement
#471Oral anti-parasitic composition
#472Compositions and methods for enhancing brain function
#473Lozenge for treating sore throat, hoarseness and associated dry cough, and inflammatory diseases of the oral and pharyngeal cavity
#474Molecular Combinations for Cancer or Other Disease Treatment
#475Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
#476Hair growth and hair restoration material
#477PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#478Probiotic recolonisation therapy
#479Probiotic recolonisation therapy
#480Probiotic recolonisation therapy
#481Probiotic recolonisation therapy
#482E-selectin antagonist compounds, compositions, and methods of use
#483Compounds and methods for treating bacterial infections
#484Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene
#485Combination of pentacyclic triterpenes and hydroxytyrosol and derivatives thereof
#486ALL NATURAL TOPICAL PAIN RELIEF CREAM
#487Compositions and methods for enhancing brain function
#488ADENOSINE ANALOGS AND THEIR USE
#489TREATMENT OF MTOR HYPERACTIVE RELATED DISEASES AND DISORDERS
#490Compositions and methods for treating or preventing metabolic syndrome disorders
#491Methods of treating a gastrointestinal spasm associated with chemotherapy or radiation therapy
#492Compositions And Methods For Immunotherapy
#493Combination comprising an omega-3 fatty acid composition and an SGLT2 inhibitor
#494Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
#495Compounds and methods for enhancing erythropoiesis
#496Synthetic lethality in cancer
#497Morpholinyl anthracycline derivatives
#498Compositions and Methods for Joint Health
#499Composition of tiacumicin compounds
#500Compositions and methods for managing or improving bone disorders, cartilage disorders, or both
#501Antibacterial compounds targeting isoprenoid biosynthesis
#502Fast acting joint relief formulations
#503Pharmaceutical composition, methods for treating and uses thereof
#504Pharmaceutical composition, methods for treating and uses thereof
#505Cholestosome vesicles for incorporation of molecules into chylomicrons
#506Semi-synthetic mithramycin derivatives with anti-cancer activity
#507Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
#508COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL
#509Prophylactic or therapeutic drug for constipation
#510PHARMACEUTICAL COMPOSITIONS INCORPORATING LOW-DOSE DRUGS
#511NERVE GROWTH INHIBITOR, CUTANEOUS-SENSORY-IRRITATION INHIBITOR, AND MARKER FOR CUTANEOUS-SENSORY-IRRITATION DETECTION
#512Stilbenoid Derivatives And Their Uses
#513Combined therapy for cystic fibrosis
#514Edible composition comprising resveratrol and flavonoid monoglucoside
#515Combination of compounds derived from gallic acid for the treatment of cancer
#516Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#517Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#518Probiotic recolonisation therapy
#519Probiotic recolonisation therapy
#520Probiotic recolonisation therapy
#521Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis
#522Selective targeting agents for mitochondria
#523Phenolic compositions derived from apple skin and uses thereof
#524METHODS OF PREVENTING TUMOR METASTASIS, TREATING AND PROGNOSING CANCER AND IDENTIFYING AGENTS WHICH ARE PUTATIVE METASTASIS INHIBITORS
#525Treatment of metabolic disorders in equine animals
#526Flavivirus protease inhibitors
#527Microbial-relief composition
#528Glucopyranosyl derivatives and their uses in medicine
#529Doxorubicin adjuvants to reduce toxicity and methods for using the same
#530TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#531Probiotic recolonisation therapy
#532Bilayer tablet formulations
#533Extracts from plants of the Moringaceae family and methods of making
#534Compounds and methods for treating bacterial infections
#535Anti-cancer agent
#536Nanoparticle delivery system for targeted anti-obesity treatment
#537Methods of treating drug side-effects that include a gastrointestinal spasm
#538Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
#539Treatment of metabolic disorders in feline animals
#540ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
#541High-purity steviol glycosides
#542PROCESS FOR PRODUCING DERIVATIVES OF PYROSTEGIA VENUSTA, DERIVATIVES OF PYROSTEGIA VENUSTA, PHARMACEUTICAL COMPOSITIONS AND ITS USES
#543USE OF HERBAL SAPONINS TO REGULATE GUT MICROFLORA
#544Methods of treating necrotic enteritis
#545E-selectin antagonist compounds, compositions, and methods of use
#546Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#547Method of Modifying Fertility
#548Cytotoxic-drug delivering molecules targeting HIV (CDM-Hs), cytotoxic activity against the human immunodeficiency virus and methods of use
#549Method for manufacturing Smilax China L root extract having increased active ingredients and beverage composition containing the extract fordetoxification
#550Compositions and methods for joint health
#551Pan-selectin inhibitor with enhanced pharmacokinetic activity
#552Total flavone extract of flower of L. medic and preparation method thereof
#553Methods and compositions for treating leukemia
#554Tannin formulation for treating malnutrition
#555Method of treating overactive bladder, not due to cancer, by administering at least one jasmonate
#556COMBINATION THERAPY COMPRISING SGLT INHIBITORS AND DPP4 INHIBITORS
#557Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#558Compositions and methods for enhancing brain function
#559Targeting the EGFR-SGLT1 interaction for cancer therapy
#560Anionic conjugates of glycosylated bacterial metabolite
#561PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#562COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL
#563Compound contained in manuka honey and use of same
#564Cancer therapy
#565Pharmaceutical composition comprising dapagliflozin and cyclodextrin
#566Foamable suspension gel
#567Pharmaceutical formulations containing an SGLT2 inhibitor
#568Compositions and methods for probiotic recolonization therapies
#569Phenolic coatings and methods of making and using same
#570Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with disease
#571Phenolic coatings and methods of making and using same
#572Selective targeting agents for mitochondria
#573Edible composition
#574HERBAL MEDICINAL COMPOSITION FOR TREATMENT OF WOMEN INFERTILITY AND A METHOD OF PREPARING THE SAME
#575COMPOUNDS AND EXTRACTS FROM GNETUM AFRICANUM AND ANTI-INFLAMMATORY ACTIVITY RELATED THERETO
#576PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#577Use of 3,8,12,14, 17,20-oxo-substituted pregnene glycosides in the preparation of healthcare products, food additives and pharmaceuticals for the inhibition of appetite
#578COMPOUNDS CONTAINING AN ALICYCLIE STRUCTURE AND ANTI-TUMOR APPLICATION
#579MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
#580PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#581Treatment to render implants resistant to diabetes
#582Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
#583Aryl glycoside compound, preparation method and use thereof
#584Compounds and methods for enhancing erythropoiesis
#585Combined therapy for cystic fibrosis
#586Crystal structures of SGLT2 inhibitors and processes for preparing same
#587Synthetic lethality in cancer
#588NEW USE OF CHEMICAL INGREDIENTS IN CYNOMORIUM AS PHYTOESTROGEN
#589TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#590Glufosfamide Combination Therapies for Cancer
#591Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
#592Foamable suspension gel
#593Compositions for probiotic recolonisation therapy
#594Pharmaceutical composition, methods for treating and uses thereof
#595Compositions for treating infection
#596SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF
#5974-isopropyl-6-methoxyphenyl glucitol compound
#598Methods of treating diabetes
#599Glycoside compounds
#600Cosmetic composition